There is accumulating evidence that the intake of nonsteroidal anti-inflammatory drugs (NSAIDs), in particular acetylsalicylic acid, may be associated with a reduced incidence of ovarian cancer among other tumors, probably via irreversible COX1 inactivation [46,47,48,49,50]. Here, PTGS1 is linked to ovarian carcinoma.